Biostem Technologies Inc
OTC:BSEM

Watchlist Manager
Biostem Technologies Inc Logo
Biostem Technologies Inc
OTC:BSEM
Watchlist
Price: 10.28 USD -14.33% Market Closed
Market Cap: 171.2m USD

Wall Street
Price Targets

BSEM Price Targets Summary
Biostem Technologies Inc

Wall Street analysts forecast BSEM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BSEM is 36.21 USD with a low forecast of 35.86 USD and a high forecast of 37.28 USD.

Lowest
Price Target
35.86 USD
249% Upside
Average
Price Target
36.21 USD
252% Upside
Highest
Price Target
37.28 USD
263% Upside
Biostem Technologies Inc Competitors:
Price Targets
DPHARMA
Duopharma Biotech Bhd
22% Upside
4887
Sawai Group Holdings Co Ltd
32% Upside
GUD
Knight Therapeutics Inc
27% Upside
GS71
GSK plc
19% Upside
216080
Jetema Co Ltd
81% Upside
INDV
Indivior PLC
1% Downside
ARVN
Arvinas Inc
82% Upside

Revenue
Forecast

Revenue Estimate
Biostem Technologies Inc

For the last 13 years the compound annual growth rate for Biostem Technologies Inc's revenue is 52%. The projected CAGR for the next 2 years is 21%.

52%
Past Growth
21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Biostem Technologies Inc

The compound annual growth rate of Biostem Technologies Inc's operating income for the next 2 years is 51%.

N/A
Past Growth
51%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Biostem Technologies Inc

The compound annual growth rate of Biostem Technologies Inc's net income for the next 2 years is 69%.

N/A
Past Growth
69%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BSEM's stock price target?
Price Target
36.21 USD

According to Wall Street analysts, the average 1-year price target for BSEM is 36.21 USD with a low forecast of 35.86 USD and a high forecast of 37.28 USD.

What is Biostem Technologies Inc's Revenue forecast?
Projected CAGR
21%

For the last 13 years the compound annual growth rate for Biostem Technologies Inc's revenue is 52%. The projected CAGR for the next 2 years is 21%.

What is Biostem Technologies Inc's Operating Income forecast?
Projected CAGR
51%

The compound annual growth rate of Biostem Technologies Inc's operating income for the next 2 years is 51%.

What is Biostem Technologies Inc's Net Income forecast?
Projected CAGR
69%

The compound annual growth rate of Biostem Technologies Inc's net income for the next 2 years is 69%.

Back to Top